Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Lipodystrophy in HIV-Infected Patients
NCT00006190Phase 4Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Sustiva/Zerit/Epivir with Viracept/Zerit/Epivir (2 arms). Primary endpoints: Metabolic changes at 2 years and Body shape changes at 2 years. Started Nov 2000; status: completed.
02
Drugs
efavirenznelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00006190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006190.